These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Free care at the point of service delivery: a key component for reaching universal access to HIV/AIDS treatment in developing countries. Souteyrand YP, Collard V, Moatti JP, Grubb I, Guerma T. AIDS; 2008 Jul; 22 Suppl 1():S161-8. PubMed ID: 18664948 [Abstract] [Full Text] [Related]
3. Out-of-pocket costs of AIDS care in China: are free antiretroviral drugs enough? Moon S, Van Leemput L, Durier N, Jambert E, Dahmane A, Jie Y, Wu G, Philips M, Hu Y, Saranchuk P. AIDS Care; 2008 Sep; 20(8):984-94. PubMed ID: 18777223 [Abstract] [Full Text] [Related]
5. The financial burden of HIV care, including antiretroviral therapy, on patients in three sites in Indonesia. Riyarto S, Hidayat B, Johns B, Probandari A, Mahendradhata Y, Utarini A, Trisnantoro L, Flessenkaemper S. Health Policy Plan; 2010 Jul; 25(4):272-82. PubMed ID: 20156918 [Abstract] [Full Text] [Related]
6. Access to antiretroviral therapy among HIV/AIDS patients in Khon Kaen Province, Thailand. Kitajima T, Kobayashi Y, Chaipah W, Sato H, Toyokawa S, Chadbunchachai W, Thuennadee R. AIDS Care; 2005 Apr; 17(3):359-66. PubMed ID: 15832884 [Abstract] [Full Text] [Related]
10. Use of protease inhibitors among persons with AIDS in Los Angeles County. Sorvillo F, Kerndt P, Odem S, Castillon M, Carruth A, Contreras R. AIDS Care; 1999 Apr; 11(2):147-55. PubMed ID: 10474618 [Abstract] [Full Text] [Related]
13. Perception of quality of care in HIV/AIDS programmes among patients in a tertiary health care facility in Anambra State. Nwabueze SA, Adogu PO, Ilika AL, Asuzu MC, Adinma ED. Niger J Med; 2011 Apr; 20(1):144-50. PubMed ID: 21970277 [Abstract] [Full Text] [Related]
14. Costing universal access of highly active antiretroviral therapy in Benin. Hounton SH, Akonde A, Zannou DM, Bashi J, Meda N, Newlands D. AIDS Care; 2008 May; 20(5):582-7. PubMed ID: 18484329 [Abstract] [Full Text] [Related]
15. Determinants of non-adherence to subsidized anti-retroviral treatment in southeast Nigeria. Uzochukwu BS, Onwujekwe OE, Onoka AC, Okoli C, Uguru NP, Chukwuogo OI. Health Policy Plan; 2009 May; 24(3):189-96. PubMed ID: 19276155 [Abstract] [Full Text] [Related]
16. [Failure of first-line antiretroviral therapy in HIV-infected children in Ouagadougou, Burkina Faso]. Kouéta F, Yé D, Zoungrana A, Sacko A, Ouédraogo-Traoré R, Kafando E, Ouédraogo S. Med Trop (Mars); 2010 Dec; 70(5-6):517-23. PubMed ID: 21520658 [Abstract] [Full Text] [Related]
17. Obstacles and proposed solutions to effective antiretroviral therapy in resource-limited settings. Bartlett JA, Hornberger J, Shewade A, Bhor M, Rajagopalan R. J Int Assoc Physicians AIDS Care (Chic); 2009 Dec; 8(4):253-68. PubMed ID: 19721103 [Abstract] [Full Text] [Related]
18. Cost of AIDS care in Mexico: what are its main individual predictors? Aracena B, Gutiérrez JP, Bertozzi SM, Gertler P. Arch Med Res; 2005 Dec; 36(5):560-6. PubMed ID: 16099339 [Abstract] [Full Text] [Related]